Clinical Trial Update: Dilapan-S®: A Multicenter US E-registry

View source ↗

Summary

A multicenter US electronic registry update for the Dilapan-S device in obstetric indications; the registry is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Gestational Diabetes Mellitus
• Gestational Hypertension
• Oligohydramnios
• Post-term Pregnancy
• Premature Rupture of Membranes

Drugs mentioned

• Dilapan-S

Snippet

Sponsor: Medicem Technology s.r.o. | Conditions: Post Term Pregnancy, Premature Rupture of Membrane | Status: ACTIVE_NOT_RECRUITING